Keywords: Pfizer, Research investment, Academia, Innovation

Pfizer to invest $100 million in Boston area academia for therapeutic innovation

Article | 10 June 2011

Print This

New York-based Pfizer (NYSE: PFE), the world’s largest drugmaker by sales, says its network of translational research partnerships, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in